Neuros Medical receives Breakthrough Device Designation from FDA

Neuros Medical Inc., a neuromodulation-focused medical device company in Willoughby Hills, said it has received Breakthrough Device Designation from the U.S. Food and Drug Administration for the use of its high-frequency nerve block technology for patients with intractable post-amputation pain.

Click here to read the complete story.

Story excerpt provided by Crain’s Cleveland Business.

Written by Scott Suttell.

Originally published June 29, 2021.